Concepedia

Publication | Open Access

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study

DOIFull Paper Access

32

Citations

8

References

2014

Year

Zhanna Kobalava, S. V. Villevalde, Yu. V. Kotovskaya, Holger Hinrichsen, Marc Petersen‐Sylla, Andreas Zaehringer, Yinuo Pang, Iris Rajman, Jasna Canadi, Marion Dahlke,
British Journal of Clinical Pharmacology

Abstract

The PK and safety profile of serelaxin were not affected by hepatic impairment. No dose adjustment is needed for serelaxin treatment of 48 h i.v. infusion in patients with hepatic impairment.

References

YearCitations

Page 1